Related Experiment Video
Updated: Apr 13, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
8.6K
Familial hypercholesterolemia
Victoria Enchia Bouhairie1, Anne Carol Goldberg1
1Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, Campus Box 8127, 660 South Euclid, St Louis, MO 63110, USA.
Cardiology Clinics
|May 6, 2015
Summary
Familial hypercholesterolemia, an inherited cholesterol disorder, causes early cardiovascular disease. Increased physician and patient awareness and early treatment are crucial to reduce its significant health burden.
Area of Science:
- Cardiology
- Metabolic Disorders
- Genetics
Background:
- Familial hypercholesterolemia (FH) is a prevalent genetic condition affecting cholesterol metabolism.
- It significantly increases the risk of premature cardiovascular morbidity and mortality.
- FH is frequently underdiagnosed and undertreated, exacerbating its impact.
Purpose of the Study:
- To highlight the critical need for increased awareness of Familial Hypercholesterolemia among healthcare providers and the general public.
- To emphasize the importance of early diagnosis and intervention in managing this inherited cholesterol disorder.
- To underscore the potential of available treatments in mitigating cardiovascular risks associated with FH.
Main Methods:
- Review of current therapeutic strategies for lowering low-density lipoprotein (LDL) cholesterol in FH patients.
- Analysis of the impact of early treatment on cardiovascular event reduction.
- Discussion on the significance of physician and patient education for improved FH management.
Main Results:
- A range of treatments, including statins, ezetimibe, bile acid sequestrants, niacin, lomitapide, mipomersen, and LDL apheresis, are effective in reducing LDL cholesterol levels.
- Early initiation of treatment in FH patients can lead to a substantial decrease in cardiovascular events and mortality.
- Raising awareness is identified as a key factor in improving diagnosis and treatment rates.
Conclusions:
- Familial Hypercholesterolemia requires greater recognition due to its severe cardiovascular consequences.
- Prompt diagnosis and comprehensive treatment are essential for improving outcomes in FH patients.
- Enhanced awareness and education are vital to reduce the public health burden of this inherited metabolic disorder.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
2.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.0K
01:25Lipid Catabolism
1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
767
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
01:29Pharmacogenomics: Identification of New Drug Targets
92
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
92
01:18Lipids: Dietary Sources and Requirements
2.7K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.7K